News

The FDA approved the AstraZeneca and Merck medications for a select subset of individuals with severe early-stage breast cancer, after chemotherapy before or after surgery. The patient's tumour must have BRCA mutations in the germline and be HER2-negative. According to...

On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022,to set new standards in digital and patient innovation for clinical transformation. The catalyst for this has been the...

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that it has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has...

Food poisoning occurs when harmful pathogens such as parasites, toxins, bacteria, or viruses contaminate food and cause illness. The terms foodborne disease or foodborne illness are used interchangeably to describe the condition. Patients may feel irritation, infection, or inflammation...

Cedars-Sinai researchers have discovered a potential new COVID-19 treatment: a biologic material made from reengineered cell cultures. When tested in human lung cells, scientists discovered that the chemical blocked SARS-CoV-2, the causative agent of COVID-19, from replicating and also...

CPhI Japan 2022 returns as a SMART event – with live exhibition at the Big Sight Exhibition Center in Tokyo (20-22 April) alongside an online networking platform – as CPhI data confirms the country continues to top global ‘API...

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’...